Microbix Biosystems Stock Performance
| MBXBF Stock | USD 0.22 0.01 4.76% |
The company secures a Beta (Market Risk) of -0.58, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Microbix Biosystems are expected to decrease at a much lower rate. During the bear market, Microbix Biosystems is likely to outperform the market. At this point, Microbix Biosystems has a negative expected return of -0.23%. Please make sure to verify Microbix Biosystems' information ratio, skewness, price action indicator, as well as the relationship between the treynor ratio and rate of daily change , to decide if Microbix Biosystems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Microbix Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 10 M |
Microbix |
Microbix Biosystems Relative Risk vs. Return Landscape
If you would invest 26.00 in Microbix Biosystems on April 20, 2025 and sell it today you would lose (4.00) from holding Microbix Biosystems or give up 15.38% of portfolio value over 90 days. Microbix Biosystems is currently producing negative expected returns and takes up 2.8346% volatility of returns over 90 trading days. Put another way, 25% of traded otc stocks are less volatile than Microbix, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Microbix Biosystems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbix Biosystems' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Microbix Biosystems, and traders can use it to determine the average amount a Microbix Biosystems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MBXBF |
Estimated Market Risk
| 2.83 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Microbix Biosystems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microbix Biosystems by adding Microbix Biosystems to a well-diversified portfolio.
Microbix Biosystems Fundamentals Growth
Microbix OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Microbix Biosystems, and Microbix Biosystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbix OTC Stock performance.
| Return On Equity | -0.0171 | |||
| Return On Asset | 0.0056 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 37.83 M | |||
| Shares Outstanding | 138.45 M | |||
| Price To Earning | 37.00 X | |||
| Price To Book | 2.48 X | |||
| Price To Sales | 2.14 X | |||
| Revenue | 19.08 M | |||
| EBITDA | 3.73 M | |||
| Cash And Equivalents | 14.16 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 4.71 M | |||
| Debt To Equity | 0.24 % | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | 3.47 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 33.15 M | |||
About Microbix Biosystems Performance
By analyzing Microbix Biosystems' fundamental ratios, stakeholders can gain valuable insights into Microbix Biosystems' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Microbix Biosystems has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Microbix Biosystems has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. MICROBIX BIOSYSTEMS operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 100 people.Things to note about Microbix Biosystems performance evaluation
Checking the ongoing alerts about Microbix Biosystems for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Microbix Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| About 13.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Microbix Biosystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbix Biosystems' stock is overvalued or undervalued compared to its peers.
- Examining Microbix Biosystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbix Biosystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbix Biosystems' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Microbix Biosystems' otc stock. These opinions can provide insight into Microbix Biosystems' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Microbix OTC Stock analysis
When running Microbix Biosystems' price analysis, check to measure Microbix Biosystems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbix Biosystems is operating at the current time. Most of Microbix Biosystems' value examination focuses on studying past and present price action to predict the probability of Microbix Biosystems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbix Biosystems' price. Additionally, you may evaluate how the addition of Microbix Biosystems to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |